Ablasyon/Ablation | 1 |
Ac-225-DOTATATE/Ac-225-DOTATATE | 300 |
Ac-225/Ac-225 | 300 |
Adjuvan tedavi/Adjuvant treatment | 1 |
Akciğer kanseri/Lung cancer | 146 |
Akciğer/Lungs | 252 |
Anti tiroglobulin antikoru/Antithyroglobulin anti-body | 63 |
Anti-tiroglobulin/Anti-thyroglobulin | 55 |
Baş boyun tümörleri/Ead and neck tumors | 139 |
Bilgisayarlı tomografi/Computerized tomography | 278 |
Çocuk/Children | 187 |
Diferansiye tiroid kanseri/Differentiated thyroid cancer | 47, 63, 93 |
Diferansiye tiroid kanseri/Differentiated thyroid carcinoma | 1 |
Dozimetri yönetmeliği/Regulations for dozimetry | 310 |
Endometrium kanseri/Endometrial cancer | 166 |
Enoskopik polipektomi/Endoscopic polypectomy | 263 |
Exendin-4/Exendin-4 | 331 |
F-18 DOPA/F-18 DOPA | 80 |
F-18 FDG PET/BT/F-18 FDG PET/CT | 177 |
F-18 FDG/F-18 FDG | 80 |
FDG PET/BT/FDG PET/CT | 146 |
FDG PET/BT/FDG PET/CT | 241 |
FDG/FDG | 139 |
Feokromasitoma/Pheochromocytoma | 293 |
Ga-68 DOTATATE PET/Ga-68 DOTATATE PET | 236 |
Ga-68 DOTATATE/Ga-68 DOTATATE | 80, 293 |
Ga-68 PSMA-PET/ BT/Ga-68 PSMA-PET/CT | 246 |
Gastrik tümör/Gastric tumors | 263 |
Gastrointestinal/Gastrointestinal | 252 |
GIP/GIP | 331 |
GLP-1R/GLP-1R | 331 |
Grad 3/Grade | 274 |
Hastaya özel dozimetri/Patient-specific dosimetry | 310 |
Hedefe yönelik tedaviler/Targeted therapies | 270 |
I-123/I-123 | 70 |
I-131 tedavisi/I-131 treatment | 1 |
I-131/I-131 | 70 |
İmmünoterapi/Immunotherapy | 196 |
İnterferans/Interference | 55 |
İyi diferansiye tiroid kanseri/Well differentiated thyroid cancer | 122 |
İyi diferansiye tiroid kanserleri/Differentiated thyroid | |
cancers | 55 |
Kanser/Cancer | 187, 196 |
Karsinoid kriz/Carcinoid crisis | 316 |
Kolorektal kanser/Colorectal carcinoma | 241 |
Kontrastlı bilgisayarlı tomografi/Contrast-enhanced computed tomography | 80 |
Kromogranin A/Chromogranin A | 316 |
Lenf nodu metastazı/Lymph nodes metastasis | 93 |
Lenfoma/Lymphoma | 177 |
Levotiroksin/Levothyroxine | 33 |
Lu-177 dozimetri/Lu-177 dosimetry | 310 |
Lu-177-DOTATATE/Lu-177-DOTATATE | 300 |
Malignite/Malignancy | 187 |
Manyetik rezonans görüntüleme/Magnetic resonance imaging | 80 |
Manyetik rezonans/Magnetic resonance | 278 |
Meme kanseri/Breast cancer | 157 |
Metastatik nöroendokrin tümör/Metastatic neuroendocrine tumor | 270 |
Minigastrin/Minigastrin | 331 |
Neden dozimetri/Why dosimetry | 310 |
Nöroendokrin karsinom/Neuroendocrine carcinoma | 252, 274 |
Nöroendokrin neoplazileri/Neuroendocrine neoplasms | 331 |
Nöroendokrin tümör/Neuroendocrine tumor | 236, 274, 278, 285, 300, 316 |
Nöroendokrin tümör/Neuroendocrine tumors | 263, 326 |
Nöroendokrin tümör/Neuroendocrine tumour | 252 |
Oktreotid/Octreotide | 300, 316 |
Onkoloji/Oncology | 220 |
Over kanseri/Ovarian cancer | 166 |
Pankreas/Pancreas | 252 |
Paragangliomalarda/Paragangliomas | 293 |
Pediatri/Pediatrics | 122 |
Pediatrik/Pediatric | 187 |
Peptid reseptör radyonüklit tedavi/Peptide receptor | |
radionuclide therapy | 293 |
PET/BT/PET/CT | 139, 157, 166, 187, 196 |
PET/MR/PET/MRI | 220 |
PET/PET | 285 |
Pozitron emisyon tomografi/Positron emission | |
tomography | 132, 212 |
Pozitron emisyon tomografisi/Positron emission tomography | 80 |
Prostat kanseri/Prostate cancer | 246 |
PRRT/PRRT | 300 |
PSMA/PSMA | 246 |
Radyoaktif iyot tedavisi/Radioactive iodine treatment | 47 |
Radyoaktif iyot/Radioactive iodine | 70 |
Radyoembolizasyon/Radioembolization | 326 |
Radyoiyot tedavisi/Radioiodine treatment | 101 |
Radyoiyot/Radioiodine | 113 |
Radyolojik görüntüleme/Radiologic imaging | 278 |
Radyonüklit görüntüleme/Radionuclide imaging | 70 |
Radyoterapi/Radiotherapy | 212 |
Rekürrens/Recurrence | 93 |
rTSH/rTSH | 113 |
Serviks kanseri/Cervical cancer | 166 |
Somatostatin analogları/Somatostatin analogs | 270 |
Somatostatin reseptör antagonistleri/Somatostatin receptor antagonists | 331 |
Somatostatin/Somatostatine | 285 |
SPECT/SPECT | 285 |
Standardizasyon/Standardization | 132 |
TARE/TARE | 326 |
Tedavi cevabı/Therapy response | 246 |
Tedavi yanıt/Treatment response | 241 |
Tedavi yanıtı/Response to therapy | 132 |
Tedavi yanıtı/Therapy response | 236 |
Tedavi yanıtı/Treatment response | 139, 146, 177, 187, 196, 220 |
Tedavi yanıtının değerlendirilmesi/Treatment response evaluation | 157 |
Tedavi/Therapy | 122 |
Tedaviye yanıt/Treatment response | 212 |
Tedaviye yanıtı değerlendirme/Treatment response evaluation | 166 |
Teranostik/Theranostic | 293 |
Teranostik/Theranostics | 300 |
Tiroglobulin/Thyroglobulin | 47, 63, 113 |
Tiroid kanseri/Thyroid cancer | 33, 70, 80, 113 |
Tiroid/Thyroid | 101 |
Tirotropin supresyonu/Thyrotropin suppression | 33 |
Vulva-vajen kanseri/Vulva-vaginal cancer | 166 |
Yan etkiler/Adverse effects | 101 |
Yttrium-90/Yttrium-90 | 326 |